Diamonds and Dogs


Under Armour (UAA) flexing its muscles. Under Armour is up 16% to a three month high following earnings. The earnings were inline, but revenue for the quarter grew 5%, or 4% excluding currency changes, to $1.365 billion ahead of expectations. International revenue jumped 47% offsetting a 4% decline in North America. International business contributed 23% of total revenue. Footwear sales increased 9% to $246 million, helping to make up for a 2% decline in apparel, to $952 million. Gross margins declined by 1.5 percentage points, to 43.2%, a sign that discounting was behind the higher sales. Inventory remains highs, guidance for the next quarter was not good, but a large percent of the outstanding shares are short so the stock goes up.

Xerox (XRX) under pressure. The stock is down 2% not far from a 52 week low after the third largest shareholder,  Darwin Deason sues to block Xerox's plan to turn over control to Fujifilm Holding Corp. Deason is calling the deal a one-sided transaction that leaves Xerox investors virtually powerless. In the complaint, the lawsuit states, "improper and fraudulently concealed 'crown jewel' lock-up agreement that Xerox entered into with Fuji 17 years ago, that was never disclosed to Xerox's shareholders before the signing of the Xerox/Fuji transaction." Carl Icahn, Xerox's second-biggest investor, also opposes the deal saying it "dramatically undervalues" the Xerox.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.